Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Omicron variant [2021-2022]: A new chapter in the COVID-19 Pandemic


Affiliations
1 Dipartment, Ahinsa Institute of Pharmacy, Dondaicha; 425408, India
2 Dipartment, Ahinsa Institute of Pharmacy, Dondaicha; 425408., India
     

   Subscribe/Renew Journal


Omicron was first identified in Botswana earlier in November. It was reported to World Health Organization (WHO) from South Africa on November 24, 2021, which was designated as a variant of concern (VOC) on November 26, 2021.The Omicron variant is thought to be at least three times more infectious than the original SARS-CoV-2 and possibly more so than the delta variant. Omicron contains a large number of mutations that were previously reported in other VOCs including at least 32 mutations in the spike protein alone compared to the 16 mutations in the already highly infectious delta variant. europe’s first case of the variant was confirmed in Belgium on 26 November in a person who tested positive for covid-19 on 22 November. By 29 November cases had been reported in the Netherlands, France, Germany, Portugal, and Italy. The UK had recorded nine cases by the morning of 29 November, six of them in Scotland. According to Brihan Mumbai Municipal Corporation (BMC), a 37-year-old man, who landed in Mumbai from South Africa on November 25, was found infected with Omicron along with one of his contacts - a 36-year-old female friend who arrived in the city from the US the same day.

Keywords

Omicron Variant, SARS-COV-2, Nextstrain clade, stigmatization.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Characteristics of Omicron, a New Coronavirus-19 Variant.Author. Hayk S. Arakelyan. Full Professor in Medicine, Doctor of Medical Sciences, Ph. D, Grand Ph. D .Senior Expert of Interactive Clinical Pharmacology , Drug Safety,Treatment Tactics, General Medicine and Clinical Research.President of Rare and Incurable Diseases Association.Yerevan-Armenia, TokyoJapan.

  • Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action; O.P. Choudhary: College of Veterinary Sciences and Animal Husbandry, Manish Dhawan: Punjab Agricultural University; Priyanka Choudhary: MJF College of Veterinary and Animal Sciences Jaipur.

  • www.whop.int ; Classification of Omicron (B.1.1.529): SARSCoV-2 Variant of Concern

  • Indianexpress.com; Omicron Coronavirus India Highlights, December 19: Tanzanian student studying in Rajkot university tests positive for Omicron; Updated: December 20, 2021.

  • Ceylontoday.lk; will new measures against omicron work?; published Nov 28 2021.

  • Dmerhaeyana.org; Omicron COVID Variant Symptoms, Cause, Precaution & Treatment; December 22, 2021.

  • http://dx.doi.org/10.1136/bmj.n2943; Published: 29 November 2021; Ingrid Torjesen; Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.

  • Omicron: A variant of concern; https://www.researchgate.net/publication/357013350

  • Thehindu.com; fresh cases in Maharashtra Gujarat take India Omicron tally to 4; Jacob Koshy, Mahesh Langa, Alok Deshpande.

  • www.timesnownews.com ; How to pronounce Omicron, the new COVID- 19 Variant.

  • COVID-19- Wikipedia; https://images.app.goo.gl/4fThNqHCCUFn5S2L7

  • www.unicef.org ; What we know about the Omicron variant; 17 December 2021

  • Cdc.gov; SARS-CoV-2 Variant Classifications and Definitions; Updated Dec. 1, 2021

  • SARS-CoV-2 Omicron variant: Characteristics and prevention; Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, XiaweiWei; MedComm; Accepted: 7 December 2021.

  • Symptoms of COVID-19; https://www.cdc.gov/; Updated Feb. 22, 2021.


Abstract Views: 110

PDF Views: 0




  • Omicron variant [2021-2022]: A new chapter in the COVID-19 Pandemic

Abstract Views: 110  |  PDF Views: 0

Authors

Prasad J. Rodge
Dipartment, Ahinsa Institute of Pharmacy, Dondaicha; 425408, India
Mansi B. Rawal
Dipartment, Ahinsa Institute of Pharmacy, Dondaicha; 425408, India
Vinit S. Khairnar
Dipartment, Ahinsa Institute of Pharmacy, Dondaicha; 425408., India

Abstract


Omicron was first identified in Botswana earlier in November. It was reported to World Health Organization (WHO) from South Africa on November 24, 2021, which was designated as a variant of concern (VOC) on November 26, 2021.The Omicron variant is thought to be at least three times more infectious than the original SARS-CoV-2 and possibly more so than the delta variant. Omicron contains a large number of mutations that were previously reported in other VOCs including at least 32 mutations in the spike protein alone compared to the 16 mutations in the already highly infectious delta variant. europe’s first case of the variant was confirmed in Belgium on 26 November in a person who tested positive for covid-19 on 22 November. By 29 November cases had been reported in the Netherlands, France, Germany, Portugal, and Italy. The UK had recorded nine cases by the morning of 29 November, six of them in Scotland. According to Brihan Mumbai Municipal Corporation (BMC), a 37-year-old man, who landed in Mumbai from South Africa on November 25, was found infected with Omicron along with one of his contacts - a 36-year-old female friend who arrived in the city from the US the same day.

Keywords


Omicron Variant, SARS-COV-2, Nextstrain clade, stigmatization.

References